Ismet Culcuoglu

Ismet Culcuoglu

Auto-generated profile, based on publicly available information

Ismet Culcuoglu

Department of Medical Oncology, Kütahya Training and Research Hospital, 43050, Kütahya, Turkey

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

1 November 2025 in Diabetes & Vascular Disease Research
Verified
Journal Article
Open access
IÇİsMet Çulcuoğlu
İsMet Çulcuoğlu
BPBarış Önder Pamuk
Barış Önder Pamuk
GEGökçe Eğlenoğlu
Gökçe Eğlenoğlu
MÜMert Üğe
Mert Üğe
YÜYusuf ÜZÜM
Yusuf ÜZÜM
VEVolkan Emren
Volkan Emren
Background: First-degree relatives (FDRs) of individuals with type 2 diabetes mellitus (T2DM) are at increased cardiometabolic risk due to genetic predisposition, even in the absence of overt disease. To evaluate subclinical myocardial dysfunction using speckle-tracking echocardiography (STE) and to assess serum levels of endothelial dysfunction related biomarkers, Endothelin-1 (ET-1), E-selectin, and Endocan, in normoglycemic FDRs of patients with T2DM, compared with healthy controls. Methods: This study included 151 normoglycemic participants, comprising 75 individuals in the study group and 76 in the control group. Global longitudinal and circumferential strain values were assessed using STE. Serum levels of ET-1, E-selectin, and Endocan were measured using ELISA. Results: ET-1 levels were significantly higher in the study group (p = 0.047). STE revealed lower strain values in the study group in both SAX Basal/Mid/Apical (p = 0.027) and A4C/A2C/A3C mean views (p = 0.013). E-selectin showed a negative correlation with myocardial strain values, although no significant between-group difference was observed. Conclusions: Normoglycemic FDRs of T2DM patients exhibited subclinical myocardial strain abnormalities and elevated ET-1 levels, suggesting early cardiovascular alterations associated with genetic predisposition. ET-1 and E-selectin may serve as potential biomarkers for preclinical myocardial dysfunction in at-risk individuals.

11 February 2026 in Clinical and Translational Oncology
Verified
Journal Article
Closed access
STSalih Tunbekici
Salih Tunbekici
HBHamit Bal
Hamit Bal
OKOğuzcan Kınıkoğlu
Oğuzcan Kınıkoğlu
HAHayati Arvas
Hayati Arvas
HMHarun Muğlu
Harun Muğlu
EGERDEM GOKER
ERDEM GOKER

16 November 2026
Verified
Book
Closed access
ASAbdullah Sakin
Abdullah Sakin
EÖEsra Özer
Esra Özer
ATAli Türker
Ali Türker
EUEsma Uğuztemur
Esma Uğuztemur
HKHayrani Kaya
Hayrani Kaya
IÇİsMet Çulcuoğlu
İsMet Çulcuoğlu